5 Warning Signs Your Spend Transparency Program Isn’t Audit-Ready
Many life sciences compliance teams believe their spend transparency processes are “good enough” until an auditor, a regulator, or a journalist starts asking pointed questions
Compliance
Paying HCPs Compliantly, Part 2: Global and International Payment Considerations
Why paying HCPs correctly gets harder, not easier, once your engagements cross a border — and what a defensible global payment program looks like. Part
Paying HCPs Compliantly, Part 1: US Regulatory and Payment Considerations
What it truly means to align HCP payments with US regulatory, transparency, and audit expectations — and where compliance programs hold up or unravel. Planning
The HCP Payment Compliance Checklist
A Practical, Audit-Ready Reference — Not Just a Policy Restatement This checklist breaks down HCP payment compliance into the exact categories reviewers examine, so your
Italy’s Sunshine Act Is Almost Live. Is Your Company Ready?
After years of regulatory groundwork, Italy’s healthcare transparency regime is entering its final stage before becoming enforceable. The Italian Ministry of Health has confirmed that
Planning and Conducting Compliant HCP Engagements
What it truly means to build a defensible, risk-resilient engagement program—from needs assessment through proof of performance. Healthcare Professional (HCP) engagement sits at the heart
Medispend AI Innovation Lab: AI Is Changing the Re-Identification Threat Model for Clinical Data Anonymization
AI is changing the re-identification threat model. The life sciences industry needs to stay ahead of it with rigor, practical innovation, and defensible anonymization strategies.
Staying Ahead of the Curve: What Life Sciences Compliance Professionals Need to Know Right Now
The regulatory environment for life sciences has never been more dynamic. From shifting enforcement priorities and new transparency requirements to global policy changes affecting pharmaceutical,
VA Contracting Enters a New Compliance Era: What the 2026 DEI Rule Means for Pharma Manufacturers
Federal contracting expectations are changing, again. And this time, the implications for pharmaceutical manufacturers participating in VA and Federal Supply Schedule (FSS) contracting are significant.
HCP Contracting: Reducing Risk Across U.S. and Global Regulations
Contracting with healthcare professionals (HCPs) is a necessary part of life sciences commercial and medical activities, and these arrangements are among the most highly regulated
Contact us
Ready to Grow Your Business Compliantly?
We’re happy to answer any questions you may have and help you determine which of our solutions and services best fit your needs.
Why Medispend:
- Life Sciences Focused
- End-to-End Solutions
- Regulatory Expertise
- Enterprise Scalability
- Advanced Analytics
- Trusted Partnership
What happens next?
1
We will reach out to you and schedule a call at your convenience
2
We have a discovery meeting to discuss your current processes and tools
3
We prepare a proposal with solutions and services tailored to your unique needs